SynthesisBMC cancer2026

Safety and tolerability of PARP inhibitors in cancer patients: a network meta-analysis of randomized controlled trials.

Chenyu Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.